SWOG clinical trial number
SWOG-8760
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Gastric Carcinoma
Closed
Phase
Accrual
83%
Published
Abbreviated Title
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Gastric Carcinoma
Activated
06/15/1988
Closed
01/01/1990
Publication Information Expand/Collapse
1992
High incidence of coagulopathy in phase II studies of recombinant tumor necrosis factor (rTNF) in advanced pancreatic and gastric cancers.